Uncategorized
STAT+: Are analysts too quick to gloss over Lilly’s liver case?
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. I was having a fine day yesterday until my colleague shared this game that tests how good (or how bad in my case) your color perception is.
The need-to-know this morning
- Vertex Pharma reported first-quarter earnings that generally matched consensus, although the company said it was shelving an early stage, mRNA-based therapy for cystic fibrosis due to poor tolerability. The drug, called VX-522, was being developed as part of a collaboration with Moderna.
- Pfizer and Alkermes also reported earnings.
- Viridian Therapeutics announced positive top-line results from a Phase 3 study of its drug, called elegrobart, in patients with chronic thyroid eye disease.
Cytokinetics drug Myqorzo meets twin efficacy goals in study of genetic heart disease
Cytokinetics said its drug Myqorzo significantly improved heart failure symptoms and cardiovascular fitness in patients with non-obstructive hypertrophic cardiomyopathy, an inherited heart disorder.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. I was having a fine day yesterday until my colleague shared this game that tests how good (or how bad in my case) your color perception is.
The need-to-know this morning
- Vertex Pharma reported first-quarter earnings that generally matched consensus, although the company said it was shelving an early stage, mRNA-based therapy for cystic fibrosis due to poor tolerability. The drug, called VX-522, was being developed as part of a collaboration with Moderna.
- Pfizer and Alkermes also reported earnings.
- Viridian Therapeutics announced positive top-line results from a Phase 3 study of its drug, called elegrobart, in patients with chronic thyroid eye disease.
Cytokinetics drug Myqorzo meets twin efficacy goals in study of genetic heart disease
Cytokinetics said its drug Myqorzo significantly improved heart failure symptoms and cardiovascular fitness in patients with non-obstructive hypertrophic cardiomyopathy, an inherited heart disorder.
Uncategorized
STAT+: A new attack on AMA’s billing codes
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
Brain Reid, who writes a newsletter on drug pricing policies, wrote “health care [sic]” in his Friday edition. I feel like a huge dork for laughing at that “sic” notation. Share your thoughts on the AP’s new compound noun dictum here, and send news tips to John.Wilkerson@statnews.com or John_Wilkerson.07 on Signal.
CPT codes are the new front in fraud allegations
House oversight committee Chair James Comer (R-Ky.) is taking aim at the American Medical Association, linking the biggest doctor lobby’s billing codes to potential fraud, waste, and abuse.
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
Brain Reid, who writes a newsletter on drug pricing policies, wrote “health care [sic]” in his Friday edition. I feel like a huge dork for laughing at that “sic” notation. Share your thoughts on the AP’s new compound noun dictum here, and send news tips to John.Wilkerson@statnews.com or John_Wilkerson.07 on Signal.
CPT codes are the new front in fraud allegations
House oversight committee Chair James Comer (R-Ky.) is taking aim at the American Medical Association, linking the biggest doctor lobby’s billing codes to potential fraud, waste, and abuse.
BioNTech is making big cuts to its manufacturing footprint.
The German company said in its first-quarter earnings release that up to 1,860 manufacturing staff could be impacted by its planned downsizing …
Uncategorized
Viridian data lift prospects for thyroid eye disease drug
Whereas earlier Phase 3 results disappointed Wall Street, new findings in people with “chronic” disease were viewed by analysts as much more competitive with Amgen’s Tepezza.
Whereas earlier Phase 3 results disappointed Wall Street, new findings in people with “chronic” disease were viewed by analysts as much more competitive with Amgen’s Tepezza.
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
STAT+: A new attack on AMA’s billing codes
BioNTech to scale down manufacturing, over 1,800 jobs on the line
Viridian data lift prospects for thyroid eye disease drug
Pfizer is a 2029 story but Q126 lays foundation for growth
Second life for gene therapy; Takeda Phase 2/3 win; UK cancer biotech’s $83M
Swiss manufacturing, biotech industry so far unfazed by geopolitics
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Contributors9 years ago
The final 6 ‘Game of Thrones’ episodes might feel like a full season
-
Uncategorized9 years ago
According to Dior Couture, this taboo fashion accessory is back
-
Uncategorized9 years ago
Uber and Lyft are finally available in all of New York State
-
Uncategorized9 years ago
Phillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years ago
The old and New Edition cast comes together to perform
-
Uncategorized9 years ago
Steph Curry finally got the contract he deserves from the Warriors
-
Uncategorized9 years ago
Disney’s live-action Aladdin finally finds its stars